Renal cell carcinoma echocardiography or ultrasound: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) No edit summary |
Farima Kahe (talk | contribs) No edit summary |
||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}} {{AE}} {{F.K}} | |||
{{CMG}} {{AE}} {{Rim}} {{F.K}} | |||
{{Renal cell carcinoma}} | {{Renal cell carcinoma}} | ||
==Overview== | ==Overview== | ||
Ultrasound may be helpful in the diagnosis of renal cell carcinoma. Ultrasound | [[Ultrasound]] may be helpful in the diagnosis of renal cell carcinoma. [[Ultrasound]] may be helpful when CT scan results are equivocal. | ||
==Ultrasound== | ==Ultrasound== | ||
Ultrasound may be helpful in the diagnosis of renal cell carcinoma | [[Ultrasound]] may be helpful in the diagnosis of renal cell carcinoma when CT scan results are equivocal.<ref name="pmid16339096">{{cite journal |vauthors=Cohen HT, McGovern FJ |title=Renal-cell carcinoma |journal=N. Engl. J. Med. |volume=353 |issue=23 |pages=2477–90 |date=December 2005 |pmid=16339096 |doi=10.1056/NEJMra043172 |url=}}</ref> | ||
{| | |||
{| style="border-collapse:collapse; text-align:left;" cellpadding="5" border="1" align="center" | |||
|+ '''''Use of US in Renal Cell Carcinoma<ref name="pmid23665399">{{cite journal| author=Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH et al.| title=Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. | journal=J Urol | year= 2013 | volume= 190 | issue= 2 | pages= 407-16 | pmid=23665399 | doi=10.1016/j.juro.2013.04.121 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23665399 }} </ref>''''' | |+ '''''Use of US in Renal Cell Carcinoma<ref name="pmid23665399">{{cite journal| author=Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH et al.| title=Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. | journal=J Urol | year= 2013 | volume= 190 | issue= 2 | pages= 407-16 | pmid=23665399 | doi=10.1016/j.juro.2013.04.121 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23665399 }} </ref>''''' | ||
| | | style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Patient Profile''' || style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Use of US'''|| style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Evidence Strength''' | ||
|- | |- | ||
| bgcolor="# | | bgcolor="#DCDCDC" |'''Low Risk Patient (pT1, N0, Nx)''' ||US (or CT or MRI) may be performed in patients following radical nephrectomy if initial post-op baseline image is negative||C | ||
|- | |- | ||
| bgcolor="# | | bgcolor="#DCDCDC" |'''Moderate to High Risk Patients (pT2-4N0 Nx or any stage N+)''' ||Imaging, including US, may be used every 6 months (after a baseline chest and abdominal CT or MRI within 3-6 months following surgery) for at least 3 years and annually thereafter to 5 years. Site specific imaging is warranted by clinical symptoms suggestive of recurrence or metastatic spread. Imaging (US, CXR, CT, or MRI) beyond 5 years may be performed at the discretion of the clinician|| C | ||
|} | |} | ||
Latest revision as of 16:48, 11 December 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2] Farima Kahe M.D. [3]
|
Renal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Renal cell carcinoma echocardiography or ultrasound On the Web |
|
American Roentgen Ray Society Images of Renal cell carcinoma echocardiography or ultrasound |
|
Renal cell carcinoma echocardiography or ultrasound in the news |
|
Blogs on Renal cell carcinoma echocardiography or ultrasound |
|
Risk calculators and risk factors for Renal cell carcinoma echocardiography or ultrasound |
Overview
Ultrasound may be helpful in the diagnosis of renal cell carcinoma. Ultrasound may be helpful when CT scan results are equivocal.
Ultrasound
Ultrasound may be helpful in the diagnosis of renal cell carcinoma when CT scan results are equivocal.[1]
| Patient Profile | Use of US | Evidence Strength |
| Low Risk Patient (pT1, N0, Nx) | US (or CT or MRI) may be performed in patients following radical nephrectomy if initial post-op baseline image is negative | C |
| Moderate to High Risk Patients (pT2-4N0 Nx or any stage N+) | Imaging, including US, may be used every 6 months (after a baseline chest and abdominal CT or MRI within 3-6 months following surgery) for at least 3 years and annually thereafter to 5 years. Site specific imaging is warranted by clinical symptoms suggestive of recurrence or metastatic spread. Imaging (US, CXR, CT, or MRI) beyond 5 years may be performed at the discretion of the clinician | C |
References
- ↑ Cohen HT, McGovern FJ (December 2005). "Renal-cell carcinoma". N. Engl. J. Med. 353 (23): 2477–90. doi:10.1056/NEJMra043172. PMID 16339096.
- ↑ Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH; et al. (2013). "Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline". J Urol. 190 (2): 407–16. doi:10.1016/j.juro.2013.04.121. PMID 23665399.